Lorenzo D Berlanga, MD - Medicare Family Practice in Midland, MI

Lorenzo D Berlanga, MD is a medicare enrolled "Family Medicine" physician in Midland, Michigan. He went to Michigan State University College Of Human Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Family Practice. His current practice location is 4800 N Saginaw Rd, Midland, Michigan. You can reach out to his office (for appointments etc.) via phone at (989) 839-9937.

Lorenzo D Berlanga is licensed to practice in Michigan (license number 4301072241) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063487411.

Contact Information

Lorenzo D Berlanga, MD
4800 N Saginaw Rd,
Midland, MI 48640-2953
(989) 839-9937
(989) 839-9220



Physician's Profile

Full NameLorenzo D Berlanga
GenderMale
SpecialityFamily Practice
Experience26 Years
Location4800 N Saginaw Rd, Midland, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Lorenzo D Berlanga attended and graduated from Michigan State University College Of Human Medicine in 1998
  NPI Data:
  • NPI Number: 1063487411
  • Provider Enumeration Date: 02/21/2006
  • Last Update Date: 11/11/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9830184266
  • Enrollment ID: I20040806001248

Medical Identifiers

Medical identifiers for Lorenzo D Berlanga such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063487411NPI-NPPES
P00668265OtherMIRAILROAD MEDICARE
5318523MedicaidMI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 4301072241 (Michigan)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lorenzo D Berlanga allows following entities to bill medicare on his behalf.
Entity NameMymichigan Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740230127
PECOS PAC ID: 4981501939
Enrollment ID: O20040126000905

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Entity NameMymichigan Medical Center Alma
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265596126
PECOS PAC ID: 3375451404
Enrollment ID: O20040202000975

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Entity NameMymichigan Medical Center Midland
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205889490
PECOS PAC ID: 2264323633
Enrollment ID: O20040324000137

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Entity NameMymichigan Medical Center Clare
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1225081862
PECOS PAC ID: 7012829773
Enrollment ID: O20040720000582

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Entity NameMymichigan Medical Center Gladwin
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881869774
PECOS PAC ID: 0143262915
Enrollment ID: O20081024000094

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Entity NameLorenzo Berlanga Md Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922513555
PECOS PAC ID: 2769741172
Enrollment ID: O20180110002402

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lorenzo D Berlanga is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lorenzo D Berlanga, MD
4800 N Saginaw Rd,
Midland, MI 48640-2953

Ph: (989) 631-4545
Lorenzo D Berlanga, MD
4800 N Saginaw Rd,
Midland, MI 48640-2953

Ph: (989) 839-9937

News Archive

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

Exposure to fine particle air pollution significantly increases the risk for cardiovascular and respiratory disease

New data from a four-year study of 11.5 million Medicare enrollees show that short-term exposure to fine particle air pollution from such sources as motor vehicle exhaust and power plant emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age.

Doctor survived Cambodia's killing fields, but not Covid

Linath Lim's life was shaped by starvation. She was not yet 13 when the Khmer Rouge seized power in Cambodia and ripped her family apart. The totalitarian regime sent her and four siblings to work camps, where they planted rice and dug irrigation canals from sunrise to sunset — each surviving on two ladles of rice gruel a day. One disappeared, never to be found.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Midland, MI

Jennifer Rose Aloff, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 920 West Wackerly Street, Midland, MI 48640
Phone: 989-839-9937    Fax: 989-839-9220
Mian K Hanif, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 4009 Orchard Dr, Midland, MI 48640
Phone: 989-839-3510    
Sasha Savage, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4611 N Campus Ridge Dr, Midland, MI 48640
Phone: 989-839-3500    Fax: 989-839-3344
Sheree Clark, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 4401 N Campus Ridge Dr, Suite 2100, Midland, MI 48640
Phone: 989-837-9300    Fax: 989-837-9307
Zachary E Iles, MD
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 4009 Orchard Dr, Midland, MI 48640
Phone: 989-839-3515    
Dr. Kirk J Bortel, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3009 N Saginaw Rd, Midland, MI 48640
Phone: 989-633-1350    Fax: 989-633-1355

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.